(Q40086146)

17 September 2017

title

Roles of NSAIDs and aspirin in bleeding peptic ulcers : NSAIDs, aspirin and peptic ulcers (English)

1 reference

17 September 2017

1 reference

Ryuichi Iwakiri

1

1 reference

17 September 2017

Kazuma Fujimoto

series ordinal

2

1 reference

17 September 2017

publication date

28 May 2008

1 reference

Clinical journal of gastroenterology

17 September 2017

published in

1 reference

17 September 2017

volume

1

1 reference

17 September 2017

issue

2

1 reference

17 September 2017

page(s)

33-39

1 reference

https://scigraph.springernature.com/pub.10.1007/s12328-008-0011-6

17 September 2017

exact match

0 references

cites work

Risks of gastrointestinal bleeding during secondary prevention of vascular events with aspirin--analysis of gastrointestinal bleeding during the UK-TIA trial

1 reference

https://api.crossref.org/works/10.1007%2FS12328-008-0011-6

Aspirin and other antiplatelet agents in the secondary and primary prevention of cardiovascular disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12328-008-0011-6

Low-dose aspirin and upper gastrointestinal damage: epidemiology, prevention and treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12328-008-0011-6

Nonsteroidal anti-inflammatory drug-associated dyspepsia: the scale of the problem

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12328-008-0011-6

Risk of upper gastrointestinal bleeding and perforation associated with low-dose aspirin as plain and enteric-coated formulations

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12328-008-0011-6

Approaches to nonsteroidal anti-inflammatory drug use in the high-risk patient

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12328-008-0011-6

Association between nonsteroidal anti-inflammatory drugs and upper gastrointestinal tract bleeding/perforation: an overview of epidemiologic studies published in the 1990s

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12328-008-0011-6

Gastrointestinal toxicity of nonsteroidal antiinflammatory drugs.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12328-008-0011-6

Ulcer complications associated with anti-inflammatory drug use. What is the extent of the disease burden?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12328-008-0011-6

The gastrointestinal toxicity of aspirin: an overview of randomised controlled trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12328-008-0011-6

Prophylactic aspirin and risk of peptic ulcer bleeding

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12328-008-0011-6

Association between aspirin and upper gastrointestinal complications: systematic review of epidemiologic studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12328-008-0011-6

Risk of upper gastrointestinal bleeding associated with use of low-dose aspirin

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12328-008-0011-6

Upper gastrointestinal bleeding associated with antiplatelet drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12328-008-0011-6

Risk of uncomplicated peptic ulcer among users of aspirin and nonaspirin nonsteroidal antiinflammatory drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12328-008-0011-6

Risk of aspirin-associated major upper-gastrointestinal bleeding with enteric-coated or buffered product.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12328-008-0011-6

A high level of cyclooxygenase-2 inhibitor selectivity is associated with a reduced interference of platelet cyclooxygenase-1 inactivation by aspirin

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12328-008-0011-6

The structural basis of aspirin activity inferred from the crystal structure of inactivated prostaglandin H2 synthase

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12328-008-0011-6

Prevention of the rehaemorrhage of bleeding peptic ulcers: effects of Helicobacter pylori eradication and acid suppression

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12328-008-0011-6

Role of Helicobacter pylori infection and non-steroidal anti-inflammatory drugs in peptic-ulcer disease: a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12328-008-0011-6

Eradication of Helicobacter pylori and risk of peptic ulcers in patients starting long-term treatment with non-steroidal anti-inflammatory drugs: a randomised trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12328-008-0011-6

Current concepts in the management of Helicobacter pylori infection--the Maastricht 2-2000 Consensus Report

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12328-008-0011-6

Secondary and primary prophylaxis of gastropathy associated with nonsteroidal antiinflammatory drugs or low-dose-aspirin: a review based on four clinical scenarios

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12328-008-0011-6

Preventing recurrent upper gastrointestinal bleeding in patients with Helicobacter pylori infection who are taking low-dose aspirin or naproxen

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12328-008-0011-6

Comparison of upper gastrointestinal toxicity of rofecoxib and naproxen in patients with rheumatoid arthritis. VIGOR Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12328-008-0011-6

Gastrointestinal toxicity with celecoxib vs nonsteroidal anti-inflammatory drugs for osteoarthritis and rheumatoid arthritis: the CLASS study: A randomized controlled trial. Celecoxib Long-term Arthritis Safety Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12328-008-0011-6

A randomized trial comparing the effect of rofecoxib, a cyclooxygenase 2-specific inhibitor, with that of ibuprofen on the gastroduodenal mucosa of patients with osteoarthritis. Rofecoxib Osteoarthritis Endoscopy Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12328-008-0011-6

Risk of upper gastrointestinal ulcer bleeding associated with selective cyclo-oxygenase-2 inhibitors, traditional non-aspirin non-steroidal anti-inflammatory drugs, aspirin and combinations

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12328-008-0011-6

Risk of upper gastrointestinal complications among users of traditional NSAIDs and COXIBs in the general population

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12328-008-0011-6

Induction of cyclooxygenase 2 in gastric mucosal lesions and its inhibition by the specific antagonist delays healing in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12328-008-0011-6

Effects of inhibition of prostaglandin endoperoxide synthase-2 in chronic gastro-intestinal ulcer models in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12328-008-0011-6

Renal effects of COX-2-selective inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12328-008-0011-6

Cardiovascular events associated with rofecoxib in a colorectal adenoma chemoprevention trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12328-008-0011-6

Complications of the COX-2 inhibitors parecoxib and valdecoxib after cardiac surgery

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12328-008-0011-6

Cardiovascular risk associated with celecoxib in a clinical trial for colorectal adenoma prevention

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12328-008-0011-6

Role of Helicobacter pylori infection and nonsteroidal anti-inflammatory drug use in bleeding peptic ulcers in Japan

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12328-008-0011-6

A clinical study of Japanese patients with ulcer induced by low-dose aspirin and other non-steroidal anti-inflammatory drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12328-008-0011-6

Case-control study on the association of upper gastrointestinal bleeding and nonsteroidal anti-inflammatory drugs in Japan

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12328-008-0011-6

Up-to-date information on gastric mucosal lesions from long-term NSAID therapy in orthopedic outpatients: a study using logistic regression analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12328-008-0011-6

The physiology of gastric acid secretion

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12328-008-0011-6

Risk of upper gastrointestinal bleeding and perforation associated with Individual non-steroidal anti-inflammatory drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12328-008-0011-6

H. pylori and gastric phospholipids of peptic ulcer

21 January 2018

1 reference

12 December 2020

Endoscopic characteristics and Helicobacter pylori infection in NSAID-associated gastric ulcer

1 reference

12 December 2020

1 reference

12 December 2020

Gastrointestinal bleeding during low-dose aspirin administration for prevention of arterial occlusive events. A critical analysis.

1 reference

12 December 2020

Epidemiology of NSAID induced gastrointestinal complications.

1 reference

12 December 2020

Gastroduodenal mucosa and dyspeptic symptoms in arthritic patients during chronic nonsteroidal anti-inflammatory drug use

1 reference

12 December 2020

Clinical significance of cytotoxin-associated gene A status of Helicobacter pylori among non-steroidal anti-inflammatory drug users with peptic ulcer bleeding: a multicenter case-control study

1 reference

12 December 2020

Upper gastrointestinal disorders induced by non-steroidal anti-inflammatory drugs

1 reference

12 December 2020

Nonsteroidal antiinflammatory drug-induced ulcers: management by traditional therapies

1 reference

12 December 2020

Anti-inflammatory and upper gastrointestinal effects of celecoxib in rheumatoid arthritis: a randomized controlled trial

1 reference

12 December 2020

Synthesis and prostaglandin E2-induced secretion of surfactant phospholipid by isolated gastric mucous cells

1 reference

12 December 2020

Role of endothelial adhesion molecules in NSAID-induced gastric mucosal injury

1 reference

12 December 2020

Relationship between non-steroidal anti-inflammatory drug use and Helicobacter pylori infection in bleeding or uncomplicated peptic ulcers: A case-control study

1 reference

12 December 2020

Non-Helicobacter pylori and non-NSAID peptic ulcer disease in the Japanese population

1 reference

12 December 2020

Gastroduodenal HCO3(-) transport: characteristics and proposed role in acidity regulation and mucosal protection

1 reference

12 December 2020

10.1007/S12328-008-0011-6

Identifiers

DOI

1 reference

17 September 2017

1 reference